Literature DB >> 6889533

Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.

N Montanaro, R Dall'Olio, O Gandolfi, A Vaccheri.   

Abstract

Rat exploratory activity as well as apomorphine-induced hypermotility and stereotyped behavior were assayed following acute (60 min before) or chronic (21 days) administration of sulpiride stereoisomers and haloperidol. Parallel groups of rats were assayed for their hypermotility and stereotyped responses to challenging doses of apomorphine 7 and 21 days after discontinuation of chronic treatments. Following its acute administration, (-)-sulpiride fully antagonized apomorphine-induced hypermotility without affecting the level of animal spontaneous activity and partially counteracted stereotyped behavior. Haloperidol completely suppressed both apomorphine responses and also depressed exploratory activity. Some tolerance to the anti-apomorphine effect of (-)-sulpiride groups exhibited enhanced behavioral sensitivity to apomorphine only with respect to hypermotility, whereas haloperidol groups were supersensitive with respect to both hypermotility and stereotyped responses. The results are discussed in terms of differential dopamine receptor supersensitivity arising from prolonged administration of butyrophenone and substituted benzamide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889533     DOI: 10.1016/0014-2999(82)90595-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.

Authors:  R Dall'Olio; O Gandolfi; P Roncada; A Vaccheri; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia.

Authors:  Susan F Sonnenschein; Kathryn M Gill; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-09-18       Impact factor: 7.853

3.  Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.

Authors:  R Dall'Olio; P Roncada; A Vaccheri; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.

Authors:  A Vaccheri; R Dall'Olio; O Gandolfi; P Roncada; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

Authors:  R Castro; P Abreu; C H Calzadilla; M Rodriguez
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.

Authors:  Y Imazu; K Kobayashi; T Shohmori
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

Review 7.  Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review.

Authors:  John Yin; Alasdair M Barr; Alfredo Ramos-Miguel; Ric M Procyshyn
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.